drugset / Trial / NCT06348303
Study to Assess Drowsiness, Cognition, Fall Risk After Metaxalone 640 mg and Metaxalone 800 mg
Non-randomizedCrossoverSingle-blindPrevention
Summary
Every participant will receive Metaxalone in two (2) stages, one week after the other. A single dose of each Metaxalone dose will be taken one (1) time after a high fat meal which must be eaten within 30 minutes. Every participant will be given written tests to measure drowsiness, reaction time and thinking process and will also be asked to take walking tests to assess fall risk. Participation in this study will last approximately 2-4 weeks.
Timeline
- Start
- 2024-05-16
- Primary completion
- 2024-09-05
- Completion
- 2024-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metaxalone | Small molecule | 640 mg | Oral |
| Comparator | Metaxalone | Small molecule | 800 mg | Oral |
Indications
No indication recorded.